Nicotrol, Nicoderm nicotine patches to be reviewed by NDAC for OTC marketing.
This article was originally published in The Tan Sheet
Executive Summary
NICOTROL, NICODERM RX-TO-OTC SWITCHES TO BE REVIEWED BY NDAC on April 19 in a joint meeting with members of the Drug Abuse Advisory Committee. The two products will be the first smoking cessation patch switches to be considered for OTC use by the Nonprescription Drug Advisory Committee.